Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease

Crit Care Med. 2007 Jan;35(1):96-105. doi: 10.1097/01.CCM.0000250391.89780.64.

Abstract

Objective: To evaluate the utility of serial measurements of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to detect acute cardiac dysfunction during weaning failure in difficult to wean patients with chronic obstructive pulmonary disease.

Design: Prospective observational cohort study.

Setting: A 14-bed general intensive care unit in a university hospital.

Patients: Nineteen patients mechanically ventilated for chronic obstructive pulmonary disease exacerbation who were difficult to wean.

Interventions: None.

Measurements and main results: Cardiac and hemodynamic variables, arterial and central venous blood gas, breathing pattern, respiratory mechanics, indexes of oxygen cost of breathing, and plasma levels of NT-proBNP were measured and analyzed immediately before (baseline) and at the end of a spontaneous breathing trial. Eight of 19 patients (42%) were identified with acute cardiac dysfunction at the end of the weaning trial. Baseline NT-proBNP levels were significantly higher (median 5000, interquartile range 4218 pg/mL) in these patients than in patients without evidence of acute cardiac dysfunction (median 1705, interquartile range 3491 pg/mL). Plasma levels of NT-proBNP increased significantly at the end of the spontaneous breathing trial only in patients with acute cardiac dysfunction (median 12,733, interquartile range 16,456 pg/mL, p < .05). The elevation in NT-proBNP at the end of the weaning trial had a good diagnostic performance in detecting acute cardiac dysfunction, as estimated by area under the receiver operating characteristic curve analysis (area under the curve 0.909, se 0.077, 95% confidence interval 0.69-0.98; p < .0001, cutoff = 184.7 pg/mL).

Conclusions: Serial measurements of NT-proBNP plasma levels provided a noninvasive manner to detect acute cardiac dysfunction during an unsuccessful weaning trial in difficult to wean patients with chronic obstructive pulmonary disease. The utility of this test as a complement of the standard clinical monitoring of the weaning trial deserves further investigation.

Publication types

  • Validation Study

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Blood Gas Analysis
  • Echocardiography, Transesophageal
  • Electrocardiography
  • Female
  • Heart Failure / blood*
  • Heart Failure / diagnosis*
  • Heart Failure / etiology
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Monitoring, Physiologic / methods
  • Monitoring, Physiologic / standards
  • Natriuretic Peptide, Brain / blood*
  • Oxygen Consumption
  • Peptide Fragments / blood*
  • Pilot Projects
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / therapy
  • Pulmonary Gas Exchange
  • Respiratory Mechanics
  • Sensitivity and Specificity
  • Tidal Volume
  • Ventilator Weaning*
  • Work of Breathing

Substances

  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain